Changing trends in P. Falciparum burden, immunity, and disease in pregnancy

New England Journal of Medicine

Volumn 373, Issue 17, 2015, Pages 1607-1617

  Mayor, Alfredo ^a,c   Bardají, Azucena ^a,c   Macete, Eusebio ^c   Nhampossa, Tacilta ^c,d   Fonseca, Ana Maria ^a,f   González, Raquel ^a,c   Maculuve, Sonia ^c,d   Cisteró, Pau ^a   Rupérez, Maria ^a,c   Campo, Joe ^a   Vala, Anifa ^c   Sigaúque, Betuel ^c,d   Jiménez, Alfons ^a,b   Machevo, Sonia ^c,e   De La Fuente, Laura ^a   Nhama, Abel ^c,d   Luis, Leopoldina ^c   Aponte, John J ^a,c   Acácio, Sozinho ^c,d   Nhacolo, Arsenio ^c   Chitnis, Chetan ^g   Dobaño, Carlota ^a,c   Sevene, Esperanza ^c,e   Alonso, Pedro Luis ^a,c   Menéndez, Clara ^a,c   more..

^a HOSPITAL CLÍNIC   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Centro de Investigao Em Saúde da Manhi   (Mozambique)

^d INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^e Faculdade Medicina   (Mozambique)

^f UNIVERSITY OF PORTO   (Portugal)

^g INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; IMMUNOGLOBULIN G ANTIBODY; MEFLOQUINE; PYRIMETHAMINE PLUS SULFADOXINE; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MATERNAL BLOOD; MICROSCOPY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; BLOOD; CLASSIFICATION; COST OF ILLNESS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MOZAMBIQUE; PARASITE LOAD; PARITY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; ANTIBODIES, PROTOZOAN; COST OF ILLNESS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MOZAMBIQUE; PARASITE LOAD; PARITY; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84944910064     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1406459     Document Type: Article

References (39)

1. Cohen JM, Smith DL, Cotter C, et al. Malaria resurgence: A systematic review and assessment of its causes. Malar J 2012; 11: 122.
2. Alonso PL, Brown G, Arevalo-Herrera M, et al. A research agenda to underpin malaria eradication. PLoS Med 2011; 8(1): E1000406.
3. Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol 2006; 28: 51-60.
4. Reyburn H, Mbatia R, Drakeley C, et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA 2005; 293: 1461-70.
5. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983; 61: 1005-16.
6. González R, Ataíde R, Naniche D, Menéndez C, Mayor A. HIV and malaria interactions: Where do we stand? Expert Rev Anti Infect Ther 2012; 10: 153-65.
7. Titanji K, De-Milito A, Cagigi A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006; 108: 1580-7.
8. Bouyou-Akotet MK, Ionete-Collard DE, Mabika-Manfoumbi M, et al. Prevalence of Plasmodium falciparum infection in pregnant women in Gabon. Malar J 2003; 2: 18.
9. Feng G, Simpson JA, Chaluluka E, Molyneux ME, Rogerson SJ. Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS One 2010; 5(8): E12012.
10. Kalayjian BC, Malhotra I, Mungai P, Holding P, King CL. Marked decline in malaria prevalence among pregnant women and their offspring from 1996 to 2010 on the south Kenyan Coast. Am J Trop Med Hyg 2013; 89: 1129-34.
11. Salanti A, Staalsoe T, Lavstsen T, et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 2003; 49: 179-91.
12. Yamada M, Steketee R, Abramowsky C, et al. Plasmodium falciparum associated placental pathology: A light and electron microscopic and immunohistologic study. Am J Trop Med Hyg 1989; 41: 161-8.
13. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001; 64: Suppl: 28-35.
14. O'Neil-Dunne I, Achur RN, Agbor-Enoh ST, et al. Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect Immun 2001; 69: 7487-92.
15. Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 2004; 363: 283-9.
16. Mayor A, Kumar U, Bardají A, et al. Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum. J Infect Dis 2013; 207: 1664-74.
17. Serra-Casas E, Menéndez C, Bardají A, et al. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes. J Infect Dis 2010; 201: 123-31.
18. Aitken EH, Mbewe B, Luntamo M, et al. Antibody to P. falciparum in pregnancy varies with intermittent preventive treatment regime and bed net use. PLoS One 2012; 7(1): E29874.
19. Ataíde R, Mayor A, Rogerson SJ. Malaria, primigravidae, and antibodies: knowledge gained and future perspectives. Trends Parasitol 2014; 30: 85-94.
20. Menendez C, Bardaji A, Sigauque B, et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 2008; 3(4): E1934.
21. González R, Desai M, Macete E, et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: A multicenter randomized placebo-controlled trial. PLoS Med 2014; 11(9): E1001735.
22. González R, Mombo-Ngoma G, Ouédraogo S, et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: A multicentre randomized controlled trial. PLoS Med 2014; 11(9): E1001733.
23. Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: Randomised controlled trial. Lancet 2004; 364: 1411-20.
24. Alonso PL, Saúte F, Aponte JJ, et al. Manhia DSS, Mozambique. In: INDEPTH Network. Population and health in devel-oping countries. Vol. 1. Population, health, and survival at INDEPTH sites. Ottawa: International Development Research Centre, 2002: 189-95.
25. Planche T, Krishna S, Kombila M, et al. Comparison of methods for the rapid laboratory assessment of children with malaria. Am J Trop Med Hyg 2001; 65: 599-602.
26. Swysen C, Vekemans J, Bruls M, et al. Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine. Malar J 2011; 10: 223.
27. Ordi J, Ismail MR, Ventura PJ, et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol 1998; 22: 1006-11.
28. Mayor A, Serra-Casas E, Bardají A, et al. Sub-microscopic infections and longterm recrudescence of Plasmodium falciparum in Mozambican pregnant women. Malar J 2009; 8: 9.
29. Rogerson SJ, Chaiyaroj SC, Ng K, Reeder JC, Brown GV. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med 1995; 182: 15-20.
30. Rowe JA, Moulds JM, Newbold CI, Miller LHP. Pfalciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997; 388: 292-5.
31. Bouyou-Akotet MK, Nzenze-Afène S, Mawili-Mboumba DP, Owono-Medang M, Guiyedi V, Kombila M. Trends in the prevalence of malaria and anemia at delivery in Libreville from 1995 to 2011. Sante 2011; 21: 199-203. (In French.).
32. O'Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis 2010; 10: 545-55.
33. Guinovart C, Dobao C, Bassat Q, et al. The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: A randomized controlled trial. PLoS One 2012; 7(3): E32362.
34. Megnekou R, Staalsoe T, Taylor DW, Leke R, Hviid L. Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens. Infect Immun 2005; 73: 4112-8.
35. Staalsoe T, Megnekou R, Fievét N, et al. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparuminfected erythrocytes that protect against placental parasitemia. J Infect Dis 2001; 184: 618-26.
36. Tutterrow YL, Avril M, Singh K, et al. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect Immun 2012; 80: 1479-90.
37. Snow RW, Marsh K. The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol 2002; 52: 235-64.
38. Walton GA. On the control of malaria in Freetown, Sierra Leone: control methods and the effects upon the transmission of Plasmodium falciparum resulting from the reduced abundance of Anopheles gambiae. Ann Trop Med Parasitol 1949; 43: 117-39.
39. malERA Consultative Group on Integration Strategies. A research agenda for malaria eradication: cross-cutting issues for eradication. PLoS Med 2011; 8(1): E1000404.